Henning Thorsen

Insider Reports History

Identity 1 fact
Location
Seattle, WA
SEC filing record 1 fact
SEC signature
Henning Thorsen by Eric Billings as attorney-in-fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Henning Thorsen:

Form 4 holding SVP, Commercial Operations

Adaptive Biotechnologies Corp

Security class
Common Stock
Shares / value
29,061
Estimated value
$120,022
Report date
17 May 2021
Price
$4.13
Ownership
Direct
Form 4 holding SVP, Commercial Operations

Adaptive Biotechnologies Corp

Security class
Stock Option (Right to Buy)
Shares / value
72,653
Estimated value
Report date
17 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Henning Thorsen

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .